Literature DB >> 21040297

Type I cannabinoid receptor trafficking: all roads lead to lysosome.

Raphael Rozenfeld1.   

Abstract

The majority of G-protein-coupled receptors (GPCRs) function at the cell surface, where they are activated by their ligands present in the extracellular milieu. Interestingly, type I cannabinoid receptor (CB(1) R), one of the most abundant GPCRs in the central nervous system, is predominantly intracellular. The important physiological roles of CB(1) R have sparked interest in the elucidation of the molecular mechanisms underlying the trafficking of this receptor and the role of intracellular CB(1) Rs. Thus far, results from different groups have been, at least in part, contradictory and the basis of CB(1) R intracellular localization remains controversial. In this commentary, by comparing the studies examining CB(1) R trafficking and localization, we identify technical or experimental ground responsible for the conflicting results. Finally, we propose a possible mechanism of CB(1) R trafficking that may reconcile the different models.
© 2010 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21040297     DOI: 10.1111/j.1600-0854.2010.01130.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  17 in total

1.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

2.  Molecular-interaction and signaling profiles of AM3677, a novel covalent agonist selective for the cannabinoid 1 receptor.

Authors:  David R Janero; Suma Yaddanapudi; Nikolai Zvonok; Kumar V Subramanian; Vidyanand G Shukla; Edward Stahl; Lei Zhou; Dow Hurst; James Wager-Miller; Laura M Bohn; Patricia H Reggio; Ken Mackie; Alexandros Makriyannis
Journal:  ACS Chem Neurosci       Date:  2015-05-29       Impact factor: 4.418

Review 3.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

4.  Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes.

Authors:  Julie T Castaneda; Airi Harui; Sylvia M Kiertscher; Jeffrey D Roth; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-10       Impact factor: 4.147

Review 5.  Endocannabinoid signalling and the deteriorating brain.

Authors:  Vincenzo Di Marzo; Nephi Stella; Andreas Zimmer
Journal:  Nat Rev Neurosci       Date:  2015-01       Impact factor: 34.870

6.  Δ9-THC increases endogenous AHA1 expression in rat cerebellum and may modulate CB1 receptor function during chronic use.

Authors:  Catalin M Filipeanu; Jesse J Guidry; Stuart T Leonard; Peter J Winsauer
Journal:  J Neurochem       Date:  2011-08-16       Impact factor: 5.372

Review 7.  The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-06-19       Impact factor: 13.382

8.  Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium.

Authors:  Luan C Koay; Rachael J Rigby; Karen L Wright
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-05-15       Impact factor: 4.052

9.  Mechanism of Diuresis and Natriuresis by Cannabinoids: Evidence for Inhibition of Na+-K+-ATPase in Mouse Kidney Thick Ascending Limb Tubules.

Authors:  Joseph K Ritter; Ashfaq Ahmad; Shobha Mummalaneni; Zdravka Daneva; Sara K Dempsey; Ningjun Li; Pin-Lan Li; Vijay Lyall
Journal:  J Pharmacol Exp Ther       Date:  2020-10-21       Impact factor: 4.030

10.  Anandamide Exerts a Differential Effect on Human Placenta Before and After the Onset of Labor.

Authors:  Paula Accialini; Cyntia Abán; Tomás Etcheverry; Mercedes Negri Malbrán; Gustavo Leguizamón; Vanesa Herlax; Sabina Maté; Mariana Farina
Journal:  Front Physiol       Date:  2021-05-21       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.